Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Deloitte
Covington
Colorcon
Chubb
McKinsey
Express Scripts
Citi
AstraZeneca

Generated: October 22, 2018

DrugPatentWatch Database Preview

CLONAZEPAM - Generic Drug Details

« Back to Dashboard

What are the generic sources for clonazepam and what is the scope of clonazepam patent protection?

Clonazepam is the generic ingredient in three branded drugs marketed by Barr, Par Pharm, Sun Pharm Inds Inc, Roche, Accord Hlthcare, Actavis Elizabeth, Apotex Inc, Mylan, Mylan Pharms Inc, Prinston Inc, Sandoz, Teva, and Watson Labs, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Forty-seven suppliers are listed for this compound.

Pharmacology for CLONAZEPAM
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for CLONAZEPAM
Synonyms for CLONAZEPAM
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
2-H-1, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
2-H-1,4-Benzodiazepin-2-one, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
2H-1, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-
2H-1, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-
2H-1,4-Benzodiazepin-2-one, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-1,4-benzodiazepin-2-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one #
5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-chlorophenyl)-7-nitro-2,3-dihydro-1H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-1,4-benzodiazepin-2-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-24-04-00351 (Beilstein Handbook Reference)
5PE9FDE8GB
622C613
7-nitro-1,3-dihydro-5-(o-chlorophenyl)-2H-1,4-benzodiazepin-2-one
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
A810362
AB01563349_01
AC-15733
AC1L1EI2
AK-61008
AKOS015902192
Alti-Clonazepam
AN-49558
Antelepsin
Antilepsin
Apetryl
BAS 00308658
BC209470
BDBM50019213
BIDD:PXR0144
BRN 0759557
C-19452
C15H10ClN3O3
CC-25924
CCG-213669
CHEBI:3756
CHEMBL452
Chlonazepam
Cloazepam
Clonazepam (JP15/USP/INN)
Clonazepam (JP17/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepam [USAN:USP:INN:BAN:JAN]
Clonazepam 0.1 mg/ml in Methanol
Clonazepam 1.0 mg/ml in Methanol
Clonazepam fine granules (JP17)
Clonazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Clonazepam solution, drug standard, 1.0 mg/mL in methanol
Clonazepam tablets (JP17)
clonazepam--dea schedule iv item
Clonazepam, European Pharmacopoeia (EP) Reference Standard
Clonazepam, powder
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
CTK4A4881
D00280
D0CP4E
DB01068
DEA No. 2737
DF2374250
DGBIGWXXNGSACT-UHFFFAOYSA-N
DivK1c_000973
DTXSID1022845
EINECS 216-596-2
FT-0603203
GTPL6963
HE061217
HE293559
HE316174
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
Landsen
Lktorivil
Lonazep
LS-34156
LS-34260
Melzap
MLS003899214
NINDS_000973
NSC 179913
NSC-179913
NSC179913
Oprea1_168772
Paxam
Ravotril
Ravotril (TN)
Rivatril
Rivatril (TN)
Rivoril
Rivotril
Rivotril (TN)
Ro 4-8180
Ro 4023
Ro 5-4023
Ro 5-4023/B-7
Ro 54023
Ro-5-4023
Ro-54023
RO4023
SBI-0206863.P001
SCHEMBL38899
SMR000058982
Solfidin
SR-01000937610
SR-01000937610-2
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC3813003

US Patents and Regulatory Information for CLONAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CLONAZEPAM clonazepam TABLET;ORAL 075150-003 Oct 5, 1998 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex Inc CLONAZEPAM clonazepam TABLET;ORAL 075468-003 Oct 6, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Inc CLONAZEPAM clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 078654-001 Aug 27, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for CLONAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KLONOPIN clonazepam TABLET;ORAL 017533-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-001 Dec 23, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-004 Dec 23, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Deloitte
Covington
Colorcon
Chubb
McKinsey
Express Scripts
Citi
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.